COVID-19 Vaccine Hesitancy Among US Adults: Safety and Effectiveness Perceptions and Messaging to Increase Vaccine Confidence and Intent to Vaccinate

Author:

Weinstein Nicole1ORCID,Schwarz Kelsey2,Chan Isabella1ORCID,Kobau Rosemarie3ORCID,Alexander Robert1,Kollar Laura4,Rodriguez Leslie1,Mansergh Gordon5,Repetski Torey1,Gandhi Pooja1,Pechta Laura6

Affiliation:

1. Karna, LLC, Atlanta, GA, USA

2. Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA

3. Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA

4. Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA

5. Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA

6. Division of Communications Science and Services, Office of Communication, Centers for Disease Control and Prevention, Atlanta, GA, USA

Abstract

Objective: Public health agencies have a critical role in providing effective messaging about mitigation strategies during a public health emergency. The objectives of this study were (1) to understand perceptions of COVID-19 vaccines, including concerns about side effects, safety, and effectiveness and how these perceptions influence vaccine decision-making among US adults and (2) to learn what messages might motivate vaccine uptake. Methods: In April and May 2021, we conducted 14 online focus groups with non-Hispanic English-speaking and English- and Spanish-speaking Hispanic adults (N = 99) not vaccinated against COVID-19. We oversampled adults aged 18-39 years and rural residents and systematically assessed 10 test messages. Researchers used a standardized guide and an a priori codebook for focus group discussions, coding transcripts, and thematic analysis. Results: Vaccine hesitancy factors included fear of the unknown; long-term side effects, including infertility; and beliefs that the vaccines were developed too quickly and were not sufficiently effective. Motivating factors for receiving vaccination included the ability to safely socialize and travel. Health care providers were considered important trusted messengers. Participants were critical of most messages tested. Messages that came across as “honest” about what is not yet known about COVID-19 vaccines were perceived more positively than other messages tested. Messages were seen as ineffective if perceived as vague or lacking in data and specificity. Conclusions: Messages that were simple and transparent about what is unknown about vaccines relative to emerging science were viewed most favorably. Health care providers, friends, and family were considered influential in vaccination decision-making. Findings underscore the benefits of research-informed strategies for developing and disseminating effective messages addressing critical issues in a public health emergency.

Funder

The Centers for Disease Control and Prevention

Publisher

SAGE Publications

Subject

Public Health, Environmental and Occupational Health

Reference37 articles.

1. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?

2. Marks P. Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine. News release. April 13, 2021. Accessed April 15, 2021. https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine

3. Hamel L, Lopes L, Sparks G, Stokes M, Brodie M. KFF COVID-19 Vaccine Monitor: April 2021. Kaiser Family Foundation. Published May 6, 2021. Accessed May 10, 2021. https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-april-2021

4. de Beaumont Foundation. Poll: the language of vaccine acceptance. Published December 28, 2020. Accessed April 15, 2021. https://debeaumont.org/changing-the-covid-conversation/vaccineacceptance

5. Son C. Five data-driven steps for more effective, more persuasive COVID-19 vaccine messaging. Civis Analytics. Published February 10, 2021. Accessed April 15, 2021. https://www.civisanalytics.com/blog/data-science/five-data-driven-steps-for-more-effective-more-persuasive-covid-19-vaccine-messaging

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3